Resolvins are pro-resolving lipid mediators with highly potent anti-inflammatory effects. Because of their polyunsaturated structures, however, they are unstable to oxygen as a drug prototype. To address this issue, we designed and synthesized CP-RvE3 as oxidatively stable congeners of RvE3 by replacing the cis-olefin with a cis-cyclopropane to avoid the unstable bisallylic structure. Although the
Resolvins 是具有高效抗炎作用的促分解脂质介质。然而,由于它们的多不饱和结构,它们对氧作为药物原型不稳定。为了解决这个问题,我们设计并合成了 CP-RvE3 作为 RvE3 的氧化稳定同系物,通过用顺式
环丙烷代替顺式烯烃来避免不稳定的
双烯丙基结构。尽管 CP-RvE3 的氧化稳定性没有提高,但 β-CP-RvE3 的代谢稳定性是 RvE3 的 3.7 倍。因此,我们将 β-CP-RvE3 鉴定为代谢稳定的等效物。